Equity Profile

FMS

Fresenius Medical Care AG

Health CareHealth Care Services$11.8B

Aug4Tue

Pre-Earnings Brief

UpcomingQ2-2023After Close9:00 AM EDT

Company Snapshot

Fresenius Medical Care AG is a leading provider of products and services for individuals with chronic kidney failure. Operating in the Health Care sector, the company plays a crucial role in delivering dialysis services and related healthcare solutions, which are essential as the global population ages and the prevalence of kidney disease increases.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

$0.50

Revenue

Revenue growth is vital for assessing the company's ability to expand its services and meet market demand.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1-2023, Fresenius Medical Care reported an EPS of $0.17, slightly below the expected $0.18, resulting in a minor stock decline. The company did not provide revenue figures for that quarter.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts are cautiously optimistic about Fresenius Medical Care's upcoming earnings, expecting an EPS of $0.50 and revenue of $4.6 billion. However, the company's recent performance has raised concerns about its ability to meet these expectations.

Bull Case

If Fresenius Medical Care exceeds EPS expectations and shows strong revenue growth, it could signal a recovery in demand for its services, leading to positive investor sentiment.

Bear Case

Conversely, if the company misses its EPS and revenue targets again, it may raise further doubts about its operational efficiency and market position, potentially leading to a significant stock decline.

Key Metrics to Watch

Earnings Per Share (EPS)

$0.50

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

Revenue

$4.6B

Revenue growth is vital for assessing the company's ability to expand its services and meet market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.50?

A beat on EPS could indicate improved operational performance and boost investor confidence after a recent miss.

What revenue figures will Fresenius report, and how do they compare to the $4.6 billion consensus?

Revenue performance is crucial for assessing the company's growth trajectory and market demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a recovery in demand for Fresenius Medical Care's services, given the aging population and increasing prevalence of kidney disease.

Supporting Evidence

The options market is pricing a 24.84% move, indicating significant uncertainty that may not be reflected in current consensus estimates.

Fresenius has historically shown resilience in demand, which could lead to a surprise in revenue growth despite recent misses.

Key Risk

If the company reports an EPS significantly above $0.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing Q1, and investors are looking for signs of recovery.

Bull Confirmed If

An EPS above $0.50 and revenue exceeding $4.6 billion would confirm the bull case.

Bear Confirmed If

An EPS below $0.47 and revenue falling short of $4.5 billion would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius Medical Care beats expectations, history suggests a modest stock increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react neutrally as investors await more clarity on future growth.

Miss

If the company misses expectations, history suggests a potential decline in stock price, reflecting ongoing concerns about operational efficiency.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on demand trends for dialysis services.
2Management's commentary on operational efficiencies and cost management.
3Insights into patient growth and retention rates.
4Guidance on future revenue expectations and market conditions.
5Any strategic initiatives that could impact long-term growth.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Aug3

ONBMO

ON Semiconductor Corporation

PreviewView

Aug3

LBMO

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

$0.50

Revenue

Revenue growth is vital for assessing the company's ability to expand its services and meet market demand.

$4.6B

Wall Street expectations, options signals, track record, and call prep available with Pro.

FMS Q2-2023 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

25%

Avg EPS Surprise

-6.74%

Avg Stock Reaction

-1.23%

Last Quarter Recap

In Q1-2023, Fresenius Medical Care reported an EPS of $0.17, slightly below the expected $0.18, resulting in a minor stock decline. The company did not provide revenue figures for that quarter.

Management Promises & Guidance

Expectations

Wall Street Expectations

Bull Case

If Fresenius Medical Care exceeds EPS expectations and shows strong revenue growth, it could signal a recovery in demand for its services, leading to positive investor sentiment.

Bear Case

Key Metrics to Watch

Earnings Per Share (EPS)

$0.50

EPS is a key indicator of the company's profitability and financial health, which investors closely watch.

Revenue

$4.6B

Revenue growth is vital for assessing the company's ability to expand its services and meet market demand.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will the EPS exceed the consensus estimate of $0.50?

A beat on EPS could indicate improved operational performance and boost investor confidence after a recent miss.

What revenue figures will Fresenius report, and how do they compare to the $4.6 billion consensus?

Revenue performance is crucial for assessing the company's growth trajectory and market demand for its services.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating the potential for a recovery in demand for Fresenius Medical Care's services, given the aging population and increasing prevalence of kidney disease.

Supporting Evidence

The options market is pricing a 24.84% move, indicating significant uncertainty that may not be reflected in current consensus estimates.

Fresenius has historically shown resilience in demand, which could lead to a surprise in revenue growth despite recent misses.

Key Risk

If the company reports an EPS significantly above $0.50, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it follows a disappointing Q1, and investors are looking for signs of recovery.

Bull Confirmed If

An EPS above $0.50 and revenue exceeding $4.6 billion would confirm the bull case.

Bear Confirmed If

An EPS below $0.47 and revenue falling short of $4.5 billion would confirm the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±24.84%

Historical Avg

±2.7%

Pricing rich

The options market is pricing in a significant potential move in either direction, indicating heightened uncertainty around the earnings report.

Options are pricing ±24.8% while FMS has averaged ±2.7% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.5%

30d HV

44.1%

Calls (500)P/C Ratio: 1.60Puts (800)

Edge

Institutional Ownership

Smart-money positioning from the most recent 13F filings.

Top holders trimming

Institutional

8.64%

of float

Insider

0.00%

of float

Holders

255

institutions

Top Holders· as of Dec 2025

Pzena Investment Management LLC
14,752,836 sh · $335.9M
2.64%
-0.4%

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Fresenius Medical Care beats expectations, history suggests a modest stock increase, confirming a recovery narrative.

In-Line / Cautious

If results are in line with expectations, the stock may react neutrally as investors await more clarity on future growth.

Miss

If the company misses expectations, history suggests a potential decline in stock price, reflecting ongoing concerns about operational efficiency.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on demand trends for dialysis services.
2Management's commentary on operational efficiencies and cost management.
3Insights into patient growth and retention rates.
4Guidance on future revenue expectations and market conditions.
5Any strategic initiatives that could impact long-term growth.